| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.15 | 5e-06 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0001 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0002 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0004 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0008 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.097 | 0.001 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |